89 reports

Bipolar Disorder (Manic Depression) - Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2019 ##.

  • Bipolar Disorder
  • Depression
  • Mental Health
  • Demand
  • Product Initiative

Treatment-Resistant Depression (TRD)—Epidemiology Forecast—2028 ##.

  • Depression
  • Germany
  • Italy
  • United Kingdom
  • United States

Treatment-Resistant Depression (TRD)—Market Insights, Epidemiology, and Market Forecast-2028 ##.

  • Depression
  • Therapy
  • United States
  • Forecast
  • Market Size

Global Unipolar Depression Epidemiology and Patient Flow Analysis - 2017 ##.

  • Depression
  • Mental Health
  • United States
  • World
  • Forecast

Global Major Depression Epidemiology and Patient Flow Analysis - 2017 ##.

  • Depression
  • Mental Health
  • United States
  • World
  • Forecast

Global Bipolar Depression Epidemiology and Patient Flow Analysis - 2017 ##.

  • Depression
  • Mental Health
  • United States
  • World
  • Forecast

Europe Unipolar Depression Epidemiology and Patient Flow Analysis - 2017 ##.

  • Depression
  • Europe
  • France
  • Germany
  • Forecast

Europe Major Depression Epidemiology and Patient Flow Analysis - 2017 ##.

  • Depression
  • Europe
  • France
  • Germany
  • Forecast

Europe Bipolar Depression Epidemiology and Patient Flow Analysis - 2017 ##.

  • Depression
  • Europe
  • France
  • Germany
  • Forecast

Global Depression Epidemiology and Patient Flow Analysis - 2016 ##.

  • Depression
  • Mental Health
  • United States
  • World
  • Forecast
  • related to depression and other mental disorders.
  • According to WHO, depression is the leading cause of disability in

Lilly' s first multibillion-dollar drug, Prozac is one of the first therapies in its class SSRI to treat clinical depression by blocking the uptake of serotonin within the human brain.

  • Depression
  • World
  • Market Size
  • Novartis AG
  • Pfizer Inc.
  • Depression
  • Strattera is indicated for the treatment of Attention-Deficit/Hyperactivity Disorder. It is also used to treat depression problems.

Johnson & Johnson is seeking to gain competitive advantage by developing nasal spray for treatment-resistant depression (which is one of the major unmet medical needs).

  • Depression
  • Allergan plc
  • Eli Lilly & Co.
  • Pfizer Inc.
  • Takeda Pharmaceutical Company Limited

Fetzima

8770 10000 7800

Fetzima CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Fetzima : Depression LIST OF FIGURES ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Fetzima for depression ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Fetzima for

  • Depression
  • Hormone
  • Mental Health
  • Therapy
  • United States

Cymbalta

8770 10000 7800

Cymbalta CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## Cymbalta : Depression ## Cymbalta : Neuropathic pain LIST OF FIGURES ## Figure ##: Datamonitor Healthcare’s drug assessment summary of Cymbalta for depression ## Figure ##: Datamonitor Healthcare’s dru

  • Chronic Pain
  • Depression
  • European Union
  • Japan
  • United States

SAGE-217

8770 10000 7800

SAGE-## CONTENTS ## OVERVIEW ## Drug Overview ## Product Profiles ## SAGE-## : Depression LIST OF FIGURES ## Figure ##: Datamonitor Healthcare’s drug assessment summary of SAGE-## for depression ## Figure ##: Datamonitor Healthcare’s drug assessment summary of SAGE-##

  • Depression
  • Mental Health
  • Pathology
  • United States
  • TYPES OF DEPRESSION
  • CAUSES & SYMPTOMS OF DEPRESSION

Various other reasons that can trigger depression are trauma, loss of loved ones, a difficult relationship, or any stressful situation.

  • Depression
  • World
  • AstraZeneca PLC
  • Lundbeck Inc.
  • Pfizer Inc.
  • MHDS - MARKET SIZE AND FORECAST 2017-2022
  • ADVANCES IN TECHNOLOGY IN TREATING MENTAL DISORDERS

AD is one of the most common types of NDDs.

  • Depression
  • Eli Lilly & Co.
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Merck & Co., Inc.

Key late-phase pipeline drugs for major depressive disorder and post-partum depression are covered, with particular focus on Johnson and Johnson’s esketamine.

  • Depression
  • Mental Health
  • United Kingdom
  • Forecast
  • Market Size
  • TOP COMPANIES PARTICIPATING IN BIPOLAR DISORDER (MANIC DEPRESSION) THERAPEUTICS CLINICAL TRIALS
  • AMONG THE EUROPEAN COUNTRIES, GERMANY HAS THE HIGHEST NUMBER OF BIPOLAR DISORDER (MANIC DEPRESSION) CLINICAL TRIALS, AS OF NOVEMBER 2018.

BIPOLAR DISORDER (MANIC DEPRESSION) THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* BIPOLAR DISORDER (MANIC DEPRESSION) THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* BIPOLAR DISORDER (MANIC DEPRESSION) THERAPEUTICS CLINICAL TRIALS,

  • Bipolar Disorder
  • Clinical Trial
  • Depression
  • Neurology
  • World
  • Depression
  • GLOBAL DEPRESSION SCREENING MARKET FOR DEPRESSION SCREENING TESTS, BY REGION,

Depression affects an estimated one in ## adults (##. ##%) per year and one in six people (##. ##%) will experience depression at some time in their life.

  • Depression
  • North America
  • United States
  • World
  • Demand
  • Clinical Trial profile. 45 Trial Title
  • Target

CLINICAL TRIALS BY END POINT STATUS POST PARTUM DEPRESSION (MATERNAL DEPRESSION / POSTNATAL DEPRESSION) THERAPEUTICS CLINICAL TRIALS, GLOBAL, BY END POINT POST PARTUM DEPRESSION (MATERNAL DEPRESSION / POSTNATAL DEPRESSION) THERAPEUTICS

  • Depression
  • Therapy
  • World
  • Product Initiative
  • SAGE Therapeutics
  • LATEST CLINICAL TRIALS NEWS ON TREATMENT RESISTANT DEPRESSION
  • TREATMENT RESISTANT DEPRESSION THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS, 2018*

TREATMENT RESISTANT DEPRESSION THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* CLINICAL TRIALS BY PHASE IN E## COUNTRIES TREATMENT RESISTANT DEPRESSION THERAPEUTICS, E## COUNTRIES, CLINICAL TRIALS BY PHASE, 2018* TREATMENT RESISTANT DEPRESSION THERAPEUTICS, E## CO

  • Clinical Trial
  • Depression
  • Therapy
  • World
  • Product Initiative

It is a very common condition that affects ## in every ## Americans.

  • Antidepressant
  • Depression
  • Mental Health
  • Therapy
  • Market Size
  • RESPIRATORY DEPRESSION (HYPOVENTILATION) THERAPEUTICS CLINICAL TRIALS, GLOBAL, ONGOING CLINICAL TRIALS BY PROMINENT DRUGS,
  • Target

RESPIRATORY DEPRESSION (HYPOVENTILATION) THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* RESPIRATORY DEPRESSION (HYPOVENTILATION) THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* RESPIRATORY DEPRESSION (HYPOVENTILATION) THERAPEUTICS C

  • Depression
  • Therapy
  • World
  • Product Initiative
  • RespireRx Pharmaceuticals Inc.
  • 5. ALL THE TRIALS INCLUDED ARE UNIQUE TRIALS.

PSYCHOTIC MAJOR DEPRESSION THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* PSYCHOTIC MAJOR DEPRESSION THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY PHASE, 2018* PSYCHOTIC MAJOR DEPRESSION THERAPEUTICS CLINICAL TRIALS, GLOBAL, TOP COMPANIES BY P

  • Depression
  • Hormone
  • Hospital
  • World
  • Product Initiative

Physician Views: Can Lundbeck and Otsuka' s newly approved Rexulti compete with branded and generic competition in the schizophrenia and depression markets?

  • Depression
  • Mental Health
  • Pathology
  • Psychotic Disorder
  • United States

Global Depressive Disorder Market DataPack (2016-2020) Types of Depression Causes & Symptoms of Depression Global Depressive Disorder Market by Value (2010-2015) Global Depressive Disorder Market Forecast by Value (2016-2020) Global Depressive Disorder Market by Region (2015) G

  • Depression
  • Mental Health
  • Pathology
  • World
  • Forecast
  • BIPOLAR DISORDER (MANIC DEPRESSION)
  • Depression - Product Development Milestones

AROUND ONE IN SIX ADULTS WILL EXPERIENCE DEPRESSION IN THEIR LIFETIMES.

  • Depression
  • United States
  • Company
  • Product Initiative
  • Anavex Life Sciences Corp.
  • 3.6.1 Epidemiological Forecast Insight

PEOPLE WHO SUFFER FROM BED STRUGGLE WITH FEELINGS OF DISGUST AND GUILT, AND FREQUENTLY SUFFER FROM CO-OCCURRING MOOD DISORDERS, SUCH AS DEPRESSION OR ANXIETY.

  • Depression
  • Mental Health
  • United States
  • World
  • Forecast
  • SUBTYPES OF MAJOR DEPRESSIVE DISORDER
  • PRESENTS THE DISEASE MANAGEMENT MODEL FOR MDD.

COND=DEPRESSION& INTR=VORTIOXETINE& PH ASE=##& RANK=##.

  • Depression
  • Alkermes plc
  • Allergan plc
  • Lundbeck Inc.
  • Otsuka Pharmaceutical Co., Ltd.